Journal of Digestive Cancer Reports

  • 제8권1호
  • /
  • Pages.1-50
  • /
  • 2020
  • /
  • 2288-1581(pISSN)
  • /
  • 2765-6713(eISSN)
대한소화기암연구학회 (Korean Society of Gastrointestinal Cancer Research)
권호 표지

조기위장관암 내시경 치료 임상진료지침

Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer

  • 박찬혁 (한양대학교 구리병원 소화기내과) ;
  • 양동훈 (서울아산병원 소화기내과) ;
  • 김정욱 (인제대학교 일산백병원 소화기내과) ;
  • 김지현 (연세대학교 강남세브란스병원 소화기내과) ;
  • 김지현 (인제대학교 부산백병원 소화기내과) ;
  • 민양원 (삼성서울병원 소화기내과) ;
  • 이시형 (영남대학교병원 소화기내과) ;
  • 배정호 (서울대학교병원 강남센터 소화기내과) ;
  • 정현수 (서울대학교병원 소화기내과) ;
  • 최기돈 (서울아산병원 소화기내과) ;
  • 박준철 (연세대학교 세브란스병원 소화기내과) ;
  • 이혁 (삼성서울병원 소화기내과) ;
  • 곽민섭 (강동경희대학교병원 소화기내과) ;
  • 김번 (국립암센터 대장암센터) ;
  • 이현정 (서울대학교병원 소화기내과) ;
  • 이혜승 (분당서울대학교병원 병리과) ;
  • 최미영 (한국보건의료연구원) ;
  • 박동아 (한국보건의료연구원) ;
  • 이종열 (국립암센터 위암센터) ;
  • 변정식 (서울아산병원 소화기내과) ;
  • 박찬국 (조선대병원 소화기내과) ;
  • 조주영 (분당차병원 소화기내과) ;
  • 이수택 (전북대학교병원 소화기내과) ;
  • 전훈재 (고려대학교 안암병원 소화기내과)
  • Park, Chan Hyuk (Department of Gastroenterology, Hanyang University Guri Hospital) ;
  • Yang, Dong-Hoon (Department of Gastroenterology, Asan Medical Center) ;
  • Kim, Jong Wook (Department of Gastroenterology, Inje University Ilsan Paik Hospital) ;
  • Kim, Jie-Hyun (Department of Gastroenterology, Yonsei University Gangnam Severance Hospital) ;
  • Kim, Ji Hyun (Department of Gastroenterology, Inje University Busan Paik Hospital) ;
  • Min, Yang Won (Department of Gastroenterology, Samsung Medical Center) ;
  • Lee, Si Hyung (Department of Gastroenterology, Yeungnam University Medical Center) ;
  • Bae, Jung Ho (Department of Gastroenterology, Seoul National University Hospital Healthcare System Gangnam Center) ;
  • Chung, Hyunsoo (Department of Gastroenterology, Seoul National University Hospital) ;
  • Choi, Kee Don (Department of Gastroenterology, Asan Medical Center) ;
  • Park, Jun Chul (Department of Gastroenterology, Yonsei University Severance Hospital) ;
  • Lee, Hyuk (Department of Gastroenterology, Samsung Medical Center) ;
  • Kwak, Min-Seob (Department of Gastroenterology, Kyung Hee University Hospital at Gangdong) ;
  • Kim, Bun (Center for Colorectal Cancer, National Cancer Center) ;
  • Lee, Hyun Jung (Department of Gastroenterology, Seoul National University Hospital) ;
  • Lee, Hye Seung (Department of Pathology, Seoul National University Bundang Hospital) ;
  • Choi, Miyoung (National Evidence-based Healthcare Collaborating Agency) ;
  • Park, Dong-Ah (National Evidence-based Healthcare Collaborating Agency) ;
  • Lee, Jong Yeul (Center for Gastric Cancer, National Cancer Center) ;
  • Byeon, Jeong-Sik (Department of Gastroenterology, Asan Medical Center) ;
  • Park, Chan Guk (Department of Gastroenterology, Chosun University Hospital) ;
  • Cho, Joo Young (Department of Gastroenterology, Cha University Bundang Medical Center) ;
  • Lee, Soo Teik (Department of Gastroenterology, Jeonbuk National University Hospital) ;
  • Chun, Hoon Jai (Department of Gastroenterology, Korea University Anam Hospital)
  • 투고 : 2020.03.30
  • 심사 : 2020.06.13
  • 발행 : 2020.06.30

⟨ 이전 논문 다음 논문 ⟩

초록

Although surgery was the standard treatment for early gastrointestinal cancers, endoscopic resection is now a standard treatment for early gastrointestinal cancers without regional lymph node metastasis. High-definition white light endoscopy, chromoendoscopy, and image-enhanced endoscopy such as narrow band imaging are performed to assess the edge and depth of early gastrointestinal cancers for delineation of resection boundaries and prediction of the possibility of lymph node metastasis before the decision of endoscopic resection. Endoscopic mucosal resection and/or endoscopic submucosal dissection can be performed to remove early gastrointestinal cancers completely by en bloc fashion. Histopathological evaluation should be carefully made to investigate the presence of risk factors for lymph node metastasis such as depth of cancer invasion and lymphovascular invasion. Additional treatment such as radical surgery with regional lymphadenectomy should be considered if the endoscopically resected specimen shows risk factors for lymph node metastasis. This is the first Korean clinical practice guideline for endoscopic resection of early gastrointestinal cancer. This guideline was developed by using mainly de novo methods and encompasses endoscopic management of superficial esophageal squamous cell carcinoma, early gastric cancer, and early colorectal cancer. This guideline will be revised as new data on early gastrointestinal cancer are collected.

키워드

참고문헌

  1. Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, Repici A, Vieth M, De Ceglie A, et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015;47(9):829-854. https://doi.org/10.1055/s-0034-1392882
  2. Eom BW, Jung KW, Won YJ, Yang H, Kim YW. Trends in gastric cancer incidence according to the clinicopathological characteristics in Korea, 1999-2014. Cancer Res Treat 2018;50(4):1343-1350. https://doi.org/10.4143/crt.2017.464
  3. Kim SG, Lyu DH, Park CM, Lee NR, Kim J, Cha Y, et al. Current status of endoscopic submucosal dissection for early gastric cancer in Korea: role and benefits. Korean J Intern Med 2019;34(4):785-793. https://doi.org/10.3904/kjim.2017.374
  4. Miyamoto S, Muto M, Hamamoto Y, Boku N, Ohtsu A, Baba S, et al. A new technique for endoscopic mucosal resection with an insulated-tip electrosurgical knife improves the completeness of resection of intramucosal gastric neoplasms. Gastrointest Endosc 2002;55(4):576-581. https://doi.org/10.1067/mge.2002.122579
  5. Bok GH, Cho JY. ESD hands-on course using ex vivo and in vivo models in South Korea. Clin Endosc 2012;45(4):358-361. https://doi.org/10.5946/ce.2012.45.4.358
  6. Park CH, Lee H, Kim DW, Chung H, Park JC, Shin SK, et al. Clinical safety of endoscopic submucosal dissection compared with surgery in elderly patients with early gastric cancer: a propensity-matched analysis. Gastrointest Endosc 2014;80(4):599-609. https://doi.org/10.1016/j.gie.2014.04.042
  7. Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20(1):1-19. https://doi.org/10.1007/s10120-016-0622-4
  8. Bosch SL, Teerenstra S, de Wilt JH, Cunningham C, Nagtegaal ID. Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy 2013;45(10):827-834. https://doi.org/10.1055/s-0033-1344238
  9. Kim TJ, Kim ER, Hong SN, Kim YH, Chang DK. Current practices in endoscopic submucosal dissection for colorectal neoplasms: A survey of indications among Korean endoscopists. Intest Res 2017;15(2):228-235. https://doi.org/10.5217/ir.2017.15.2.228
  10. Ebi M, Shimura T, Yamada T, Mizushima T, Itoh K, Tsukamoto H, et al. Multicenter, prospective trial of white-light imaging alone versus white-light imaging followed by magnifying endoscopy with narrow-band imaging for the real-time imaging and diagnosis of invasion depth in superficial esophageal squamous cell carcinoma. Gastrointest Endosc 2015;81(6):1355-1361 e2. https://doi.org/10.1016/j.gie.2014.11.015
  11. Ishihara R, Matsuura N, Hanaoka N, Yamamoto S, Akasaka T, Takeuchi Y, et al. Endoscopic imaging modalities for diagnosing invasion depth of superficial esophageal squamous cell carcinoma: a systematic review and meta-analysis. BMC Gastroenterol 2017;17(1):24. https://doi.org/10.1186/s12876-017-0574-0
  12. Nagahama T, Yao K, Maki S, Yasaka M, Takaki Y, Matsui T, et al. Usefulness of magnifying endoscopy with narrowband imaging for determining the horizontal extent of early gastric cancer when there is an unclear margin by chromoendoscopy (with video). Gastrointest Endosc 2011;74(6):1259-1267. https://doi.org/10.1016/j.gie.2011.09.005
  13. Kato M, Kaise M, Yonezawa J, Toyoizumi H, Yoshimura N, Yoshida Y, et al. Magnifying endoscopy with narrow-band imaging achieves superior accuracy in the differential diagnosis of superficial gastric lesions identified with white-light endoscopy: a prospective study. Gastrointest Endosc 2010;72(3):523-529. https://doi.org/10.1016/j.gie.2010.04.041
  14. Mocellin S, Marchet A, Nitti D. EUS for the staging of gastric cancer: a meta-analysis. Gastrointest Endosc 2011;73(6):1122-1134. https://doi.org/10.1016/j.gie.2011.01.030
  15. Backes Y, Moss A, Reitsma JB, Siersema PD, Moons LM. Narrow band imaging, magnifying chromoendoscopy, and gross morphological features for the optical diagnosis of t1 colorectal cancer and deep submucosal invasion: A systematic review and meta-analysis. Am J Gastroenterol 2017;112(1):54-64. https://doi.org/10.1038/ajg.2016.403
  16. Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, et al. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019;17(7):855-883. https://doi.org/10.6004/jnccn.2019.0033
  17. Japan Esophageal Society. Japanese classification of esophageal cancer, 11th Edition: part I. Esophagus 2017;14(1):1-36. https://doi.org/10.1007/s10388-016-0551-7
  18. Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj 2019;366:l4898.
  19. Higgins J, Green S. Cochrnae handbook for systematic reviews of interventions, Version 5.1.0, Chapter 8: Assessing risk of bias in included studies, Available at: http://handbook-5-1.cochrane.org/. Accessed July 26, 2019.
  20. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25(9):603-605. https://doi.org/10.1007/s10654-010-9491-z
  21. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155(8):529-536. https://doi.org/10.7326/0003-4819-155-8-201110180-00009
  22. Guyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, Liberati A, et al. Incorporating considerations of resources use into grading recommendations. BMJ 2008;336(7654):1170. https://doi.org/10.1136/bmj.39504.506319.80
  23. Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, et al. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw 2015;13(2):194-227. https://doi.org/10.6004/jnccn.2015.0028
  24. Endoscopic Classification Review G. Update on the paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005;37(6):570-578. https://doi.org/10.1055/s-2005-861352
  25. Lee WC, Lee TH, Jang JY, Lee JS, Cho JY, Lee JS, et al. Staging accuracy of endoscopic ultrasound performed by nonexpert endosonographers in patients with resectable esophageal squamous cell carcinoma: Is it possible. Dis Esophagus 2015;28(6):574-578. https://doi.org/10.1111/dote.12235
  26. Thosani N, Singh H, Kapadia A, Ochi N, Lee JH, Ajani J, et al. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis. Gastrointest Endosc 2012;75(2):242-253. https://doi.org/10.1016/j.gie.2011.09.016
  27. Dhupar R, Rice RD, Correa AM, Weston BR, Bhutani MS, Maru DM, et al. Endoscopic ultrasound estimates for tumor depth at the gastroesophageal junction are inaccurate: Implications for the liberal use of endoscopic resection. Ann Thorac Surg 2015;100(5):1812-1826. https://doi.org/10.1016/j.athoracsur.2015.05.038
  28. Oyama T, Inoue H, Arima M, Momma K, Omori T, Ishihara R, et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: Magnifying endoscopic classification of the Japan Esophageal Society. Esophagus 2017;14(2):105-112. https://doi.org/10.1007/s10388-016-0527-7
  29. Ra J, Paulson EC, Kucharczuk J, Armstrong K, Wirtalla C, Rapaport-Kelz R, et al. Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model. Ann Surg Oncol 2008;15(6):1577-1584. https://doi.org/10.1245/s10434-008-9867-4
  30. Chang AC, Ji H, Birkmeyer NJ, Orringer MB, Birkmeyer JD. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 2008;85(2):424-429. https://doi.org/10.1016/j.athoracsur.2007.10.007
  31. Connors RC, Reuben BC, Neumayer LA, Bull DA. Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. Journal of the American College of Surgeons 2007;205(6):735-740. https://doi.org/10.1016/j.jamcollsurg.2007.07.001
  32. Min YW, Lee H, Song BG, Min BH, Kim HK, Choi YS, et al. Comparison of endoscopic submucosal dissection and surgery for superficial esophageal squamous cell carcinoma: A propensity score-matched analysis. Gastrointest Endosc. 2018;88(4):624-633. https://doi.org/10.1016/j.gie.2018.04.2360
  33. Zhang Y, Ding H, Chen T, Zhang X, Chen WF, Li Q, et al. Outcomes of endoscopic submucosal dissection vs. Esophagectomy for T1 esophageal squamous cell carcinoma in a real-world cohort. Clin Gastroenterol Hepatol 2019;17(1):73-81 e3. https://doi.org/10.1016/j.cgh.2018.04.038
  34. Shimizu Y, Omori T, Yokoyama A, Yoshida T, Hirota J, Ono Y, et al. Endoscopic diagnosis of early squamous neoplasia of the esophagus with iodine staining: high-grade intra-epithelial neoplasia turns pink within a few minutes. J Gastroenterol Hepatol 2008;23(4):546-550. https://doi.org/10.1111/j.1440-1746.2007.04990.x
  35. Ishihara R, Kanzaki H, Iishi H, Nagai K, Matsui F, Yamashina T, et al. Pink-color sign in esophageal squamous neoplasia, and speculation regarding the underlying mechanism. World J Gastroenterol 2013;19(27):4300-4308. https://doi.org/10.3748/wjg.v19.i27.4300
  36. Uedo N, Fujishiro M, Goda K, Hirasawa D, Kawahara Y, Lee JH, et al. Role of narrow band imaging for diagnosis of early-stage esophagogastric cancer: Current consensus of experienced endoscopists in Asia-Pacific region. Dig Endosc 2011;23 Suppl 1:58-71. https://doi.org/10.1111/j.1443-1661.2011.01119.x
  37. Gai W, Jin XF, Du R, Li L, Chai TH. Efficacy of narrow-band imaging in detecting early esophageal cancer and risk factors for its occurrence. Indian J Gastroenterol 2018;37(2):79-85. https://doi.org/10.1007/s12664-017-0813-x
  38. Goda K, Dobashi A, Yoshimura N, Kato M, Aihara H, Sumiyama K, et al. Narrow-band imaging magnifying endoscopy versus lugol chromoendoscopy with pink-color sign assessment in the diagnosis of superficial esophageal squamous neoplasms: A randomised noninferiority trial. Gastroenterol Res Pract 2015;2015:639462.
  39. Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg 2017;6(2):119-130. https://doi.org/10.21037/acs.2017.03.14
  40. Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR. Staging accuracy of esophageal cancer by endoscopic ultrasound: A meta-analysis and systematic review. World J Gastroenterol 2008;14(10):1479-1490. https://doi.org/10.3748/wjg.14.1479
  41. Goda K, Tajiri H, Ikegami M, Yoshida Y, Yoshimura N, Kato M, et al. Magnifying endoscopy with narrow band imaging forpredicting the invasion depth of superficial esophageal squa mous cell carcinoma. Dis Esophagus 2009;22(5):453-460. https://doi.org/10.1111/j.1442-2050.2009.00942.x
  42. Katada C, Tanabe S, Wada T, Ishido K, Yano T, Furue Y, et al. Retrospective assessment of the diagnostic accuracy of the depth of invasion by narrow band imaging magnifying endoscopy in patients with superficial esophageal squa- mous cell carcinoma. J Gastrointest Cancer 2019;50(2):292-297. https://doi.org/10.1007/s12029-018-0075-6
  43. Ishihara R, Iishi H, Uedo N, Takeuchi Y, Yamamoto S, Yamada T, et al. Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc 2008;68(6):1066-1072. https://doi.org/10.1016/j.gie.2008.03.1114
  44. Takahashi H, Arimura Y, Masao H, Okahara S, Tanuma T, Kodaira J, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 2010;72(2):255-264, 64 e1-2. https://doi.org/10.1016/j.gie.2010.02.040
  45. Teoh AY, Chiu PW, Yu Ngo DK, Wong SK, Lau JY, Ng EK. Outcomes of endoscopic submucosal dissection versus endoscopic mucosal resection in management of superficial squamous esophageal neoplasms outside Japan. J Clin Gastroenterol 2010;44(9):e190-194. https://doi.org/10.1097/mcg.0b013e3181ce52fb
  46. Urabe Y, Hiyama T, Tanaka S, Yoshihara M, Arihiro K, Chayama K. Advantages of endoscopic submucosal dissection versus endoscopic oblique aspiration mucosectomy for superficial esophageal tumors. J Gastroenterol Hepatol 2011;26(2):275-280. https://doi.org/10.1111/j.1440-1746.2010.06503.x
  47. Yamashita T, Zeniya A, Ishii H, Tsuji T, Tsuda S, Nakane K, et al. Endoscopic mucosal resection using a cap-fitted panendoscope and endoscopic submucosal dissection as optimal endoscopic procedures for superficial esophageal carcinoma. Surgical Endoscopy 2011;25(8):2541-2546. https://doi.org/10.1007/s00464-011-1584-6
  48. Guo HM, Zhang XQ, Chen M, Huang SL, Zou XP. Endoscopic submucosal dissection vs. endoscopic mucosal resection for superficial esophageal cancer. World J Gastroenterol 2014;20(18):5540-5547. https://doi.org/10.3748/wjg.v20.i18.5540
  49. Cao Y, Liao C, Tan A, Gao Y, Mo Z, Gao F. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 2009;41(9):751-757. https://doi.org/10.1055/s-0029-1215053
  50. Ono S, Fujishiro M, Niimi K, Goto O, Kodashima S, Yamamichi N, et al. Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms. Endoscopy 2009;41(8):661-665. https://doi.org/10.1055/s-0029-1214867
  51. Hashimoto S, Kobayashi M, Takeuchi M, Sato Y, Narisawa R, Aoyagi Y. The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc 2011;74(6):1389-1393. https://doi.org/10.1016/j.gie.2011.07.070
  52. Hanaoka N, Ishihara R, Takeuchi Y, Uedo N, Higashino K, Ohta T, et al. Intralesional steroid injection to prevent stricture after endoscopic submucosal dissection for esophageal cancer: a controlled prospective study. Endoscopy 2012;44(11):1007-1011. https://doi.org/10.1055/s-0032-1310107
  53. Takahashi H, Arimura Y, Okahara S, Kodaira J, Hokari K, Tsukagoshi H, et al. A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection. BMC Gastroenterol 2015;15:1. https://doi.org/10.1186/s12876-014-0226-6
  54. Kataoka M, Anzai S, Shirasaki T, Ikemiyagi H, Fujii T, Mabuchi K, et al. Efficacy of short period, low dose oral pred nisolone for the prevention of stricture after circumferential endoscopic submucosal dissection (ESD) for esophageal cancer. Endosc Int Open 2015;3(2):E113-117.
  55. Zhou G, Yuan F, Cai J, Tang X, Gong W, Su L, et al. Efficacy of prednisone for prevention of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Thorac Cancer 2017;8(5):489-494. https://doi.org/10.1111/1759-7714.12473
  56. Yamaguchi N, Isomoto H, Nakayama T, Hayashi T, Nishiyama H, Ohnita K, et al. Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest Endosc 2011;73(6):1115-1121. https://doi.org/10.1016/j.gie.2011.02.005
  57. Sato H, Inoue H, Kobayashi Y, Maselli R, Santi EG, Hayee B, et al. Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone. Gastrointest Endosc 2013;78(2):250-257. https://doi.org/10.1016/j.gie.2013.01.008
  58. Nagami Y, Shiba M, Tominaga K, Minamino H, Ominami M, Fukunaga S, et al. Locoregional steroid injection prevents stricture formation after endoscopic submucosal dissection for esophageal cancer: A propensity score matching analysis. Surgical Endoscopy 2016;30(4):1441-1449. https://doi.org/10.1007/s00464-015-4348-x
  59. Eguchi T, Nakanishi Y, Shimoda T, Iwasaki M, Igaki H, Tachimori Y, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 2006;19(3):475-480. https://doi.org/10.1038/modpathol.3800557
  60. Akutsu Y, Uesato M, Shuto K, Kono T, Hoshino I, Horibe D, et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: A retrospective analysis of 295 patients. Ann Surg 2013;257(6):1032-1038. https://doi.org/10.1097/sla.0b013e31827017fc
  61. Choi JY, Park YS, Jung HY, Ahn JY, Kim MY, Lee JH, et al. Feasibility of endoscopic resection in superficial esophageal squamous carcinoma. Gastrointest Endosc 2011;73(5):881-9, 9 e1-2. https://doi.org/10.1016/j.gie.2010.12.028
  62. Tachibana M, Yoshimura H, Kinugasa S, Hashimoto N, Dhar DK, Abe S, et al. Clinicopathological features of superficial squamous cell carcinoma of the esophagus. American Journal of Surgery 1997;174(1):49-53. https://doi.org/10.1016/S0002-9610(97)00046-9
  63. Endo M, Yoshino K, Kawano T, Nagai K, Inoue H. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 2000;13(2):125-129. https://doi.org/10.1046/j.1442-2050.2000.00100.x
  64. Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer 2002;94(2):570-575. https://doi.org/10.1002/cncr.10190
  65. Bollschweiler E, Baldus SE, Schroder W, Prenzel K, Gutschow C, Schneider PM, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 2006;38(2):149-156. https://doi.org/10.1055/s-2006-924993
  66. Kim DU, Lee JH, Min BH, Shim SG, Chang DK, Kim YH, et al. Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol 2008;23(4):619-625. https://doi.org/10.1111/j.1440-1746.2007.05259.x
  67. Moriya H, Ohbu M, Kobayashi N, Tanabe S, Katada N, Futawatari N, et al. Lymphatic tumor emboli detected by D2-40 immunostaining can more accurately predict lymph-node metastasis. World J Surg 2011;35(9):2031-2037. https://doi.org/10.1007/s00268-011-1143-2
  68. Yamashina T, Ishihara R, Nagai K, Matsuura N, Matsui F, Ito T, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol 2013;108(4):544-551. https://doi.org/10.1038/ajg.2013.8
  69. Oyama T, Tomori A, Hotta K, Morita S, Kominato K, Tanaka M, et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol 2005;3(7 Suppl 1):S67-S70. https://doi.org/10.1016/S1542-3565(05)00291-0
  70. Katada C, Muto M, Momma K, Arima M, Tajiri H, Kanamaru C, et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae - A multicenter retrospective cohort study. Endoscopy. 2007;39(9):779-783. https://doi.org/10.1055/s-2007-966761
  71. Park HC, Kim DH, Gong EJ, Na HK, Ahn JY, Lee JH, et al. Ten-year experience of esophageal endoscopic submucosal dissection of superficial esophageal neoplasms in a single center. Korean J Intern Med 2016;31(6):1064-1072. https://doi.org/10.3904/kjim.2015.210
  72. Song BG, Min YW, Cha RR, Lee H, Min BH, Lee JH, et al. Endoscopic submucosal dissection under general anesthesia for superficial esophageal squamous cell carcinoma is associated with better clinical outcomes. BMC Gastroenterol 2018;18(1):80. https://doi.org/10.1186/s12876-018-0813-z
  73. Motoori M, Yano M, Ishihara R, Yamamoto S, Kawaguchi Y, Tanaka K, et al. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer. Annals of Surgical Oncology 2012;19(7):2135-2141. https://doi.org/10.1245/s10434-012-2231-8
  74. Kawaguchi G, Sasamoto R, Abe E, Ohta A, Sato H, Tanaka K, et al. The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer. Radiat Oncol 2015;10:31. https://doi.org/10.1186/s13014-015-0337-4
  75. Ikeda A, Hoshi N, Yoshizaki T, Fujishima Y, Ishida T, Morita Y, et al. Endoscopic submucosal dissection (ESD) with additional therapy for superficial esophageal cancer with submucosal invasion. Internal Medicine 2015;54(22):2803-2813. https://doi.org/10.2169/internalmedicine.54.3591
  76. Hamada K, Ishihara R, Yamasaki Y, Hanaoka N, Yamamoto S, Arao M, et al. Efficacy and safety of endoscopic resection followed by chemoradiotherapy for superficial esophageal squamous cell carcinoma: A retrospective study. Clin Transl Gastroenterol 2017;8(8):e110. https://doi.org/10.1038/ctg.2017.36
  77. Kurokawa Y, Muto M, Minashi K, Boku N, Fukuda H, Gastrointestinal Oncology Study Group of Japan Clinical Oncology G. A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508. Japanese Journal of Clinical Oncology 2009;39(10):686-689. https://doi.org/10.1093/jjco/hyp078
  78. Minashi K, Nihei K, Mizusawa J, Takizawa K, Yano T, Ezoe Y, et al. Efficacy of endoscopic resection and selective chemoradiotherapy for stage i esophageal squamous cell carcinoma. Gastroenterology 2019;157(2):382-390 e3. https://doi.org/10.1053/j.gastro.2019.04.017
  79. Ezoe Y, Muto M, Uedo N, Doyama H, Yao K, Oda I, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology 2011;141(6):2017-2025.e3. https://doi.org/10.1053/j.gastro.2011.08.007
  80. Kawahara Y, Takenaka R, Okada H, Kawano S, Inoue M, Tsuzuki T, et al. Novel chromoendoscopic method using an acetic acid-indigocarmine mixture for diagnostic accuracy in delineating the margin of early gastric cancers. Dig Endosc 2009;21(1):14-19. https://doi.org/10.1111/j.1443-1661.2008.00824.x
  81. Lee BE, Kim GH, Park DY, Kim DH, Jeon TY, Park SB, et al. Acetic acid-indigo carmine chromoendoscopy for delineating early gastric cancers: Its usefulness according to histological type. BMC Gastroenterol 2010;10:97. https://doi.org/10.1186/1471-230X-10-97
  82. Tsujii Y, Kato M, Inoue T, Yoshii S, Nagai K, Fujinaga T, et al. Integrated diagnostic strategy for the invasion depth of early gastric cancer by conventional endoscopy and EUS. Gastrointest Endosc 2015;82(3):452-459. https://doi.org/10.1016/j.gie.2015.01.022
  83. Choi J, Kim SG, Im JP, Kim JS, Jung HC, Song IS. Is endoscopic ultrasonography indispensable in patients with early gastric cancer prior to endoscopic resection. Surg Endosc 2010;24(12):3177-1785. https://doi.org/10.1007/s00464-010-1112-0
  84. Choi J, Kim SG, Im JP, Kim JS, Jung HC, Song IS. Comparison of endoscopic ultrasonography and conventional endoscopy for prediction of depth of tumor invasion in early gastric cancer. Endoscopy 2010;42(9):705-713. https://doi.org/10.1055/s-0030-1255617
  85. Yanai H, Noguchi T, Mizumachi S, Tokiyama H, Nakamura H, Tada M, et al. A blind comparison of the effectiveness of endoscopic ultrasonography and endoscopy in staging early gastric cancer. Gut 1999;44(3):361-365. https://doi.org/10.1136/gut.44.3.361
  86. Yanai H, Matsumoto Y, Harada T, Nishiaki M, Tokiyama H, Shigemitsu T, et al. Endoscopic ultrasonography and endoscopy for staging depth of invasion in early gastric cancer: A pilot study. Gastrointest Endosc 1997;46(3):212-216. https://doi.org/10.1016/S0016-5107(97)70088-9
  87. Okada K, Fujisaki J, Kasuga A, Omae M, Yoshimoto K, Hirasawa T, et al. Endoscopic ultrasonography is valuable for identifying early gastric cancers meeting expanded-indication criteria for endoscopic submucosal dissection. Surgical Endoscopy 2011;25(3):841-848. https://doi.org/10.1007/s00464-010-1279-4
  88. Akashi K, Yanai H, Nishikawa J, Satake M, Fukagawa Y, Okamoto T, et al. Ulcerous change decreases the accuracy of endoscopic ultrasonography diagnosis for the invasive depth of early gastric cancer. Int J Gastrointest Cancer 2006;37(4):133-138. https://doi.org/10.1007/s12029-007-9004-9
  89. Yoshida S, Tanaka S, Kunihiro K, Mitsuoka Y, Hara M, Kitadai Y, et al. Diagnostic ability of high-frequency ultrasound probe sonography in staging early gastric cancer, especially for submucosal invasion. Abdominal Imaging 2005;30(5):518-523. https://doi.org/10.1007/s00261-004-0287-z
  90. Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000;3(4):219-225. https://doi.org/10.1007/PL00011720
  91. Nishizawa T, Yahagi N. Long-Term Outcomes of Using Endoscopic Submucosal Dissection to Treat Early Gastric Cancer. Gut Liver 2018;12(2):119-124. https://doi.org/10.5009/gnl17095
  92. Abdelfatah MM, Barakat M, Lee H, Kim JJ, Uedo N, Grimm I, et al. The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: A systematic review of the literature and meta-analysis. Gastrointest Endosc 2018;87(2):338-347. https://doi.org/10.1016/j.gie.2017.09.025
  93. Choi KS, Jung HY, Choi KD, Lee GH, Song HJ, Kim DH, et al. EMR versus gastrectomy for intramucosal gastric cancer: Comparison of long-term outcomes. Gastrointest Endosc 2011;73(5):942-948. https://doi.org/10.1016/j.gie.2010.12.032
  94. Choi IJ, Lee JH, Kim YI, Kim CG, Cho SJ, Lee JY, et al. Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointest Endosc 2015;81(2):333-341 e1. https://doi.org/10.1016/j.gie.2014.07.047
  95. Hahn KY, Park CH, Lee YK, Chung H, Park JC, Shin SK, et al. Comparative study between endoscopic submucosal dissection and surgery in patients with early gastric cancer. Surgical Endoscopy 2018;32(1):73-86. https://doi.org/10.1007/s00464-017-5640-8
  96. Choi JH, Kim ES, Lee YJ, Cho KB, Park KS, Jang BK, et al. Comparison of quality of life and worry of cancer recurrence between endoscopic and surgical treatment for early gastric cancer. Gastrointest Endosc 2015;82(2):299-307. https://doi.org/10.1016/j.gie.2015.01.019
  97. Kim JH, Kim SS, Lee JH, Jung DH, Cheung DY, Chung WC, et al. Early detection is important to reduce the economic burden of gastric cancer. J Gastric Cancer 2018;18(1):82-89. https://doi.org/10.5230/jgc.2018.18.e7
  98. Kim YI, Kim YA, Kim CG, Ryu KW, Kim YW, Sim JA, et al. Serial intermediate-term quality of life comparison after endoscopic submucosal dissection versus surgery in early gastric cancer patients. Surgical Endoscopy 2018;32(4):2114-2122. https://doi.org/10.1007/s00464-017-5909-y
  99. Kim TS, Min BH, Kim KM, Lee JH, Rhee PL, Kim JJ. Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: low curative resection rate but favorable long-term outcomes after curative resection. Gastric Cancer 2019;22(2):363-368. https://doi.org/10.1007/s10120-018-0857-3
  100. Lee SC, KD Han, M Na, HK Ahn, JY Jung, KW Lee, JH Kim, DH Song, HJ Lee, GH Yook, JH Kim, BS Jung, HY. Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: A criteria-based analysis. Gastric Cancer 2018;21(3):490-499. https://doi.org/10.1007/s10120-017-0772-z
  101. Min BH, Kim ER, Kim KM, Park CK, Lee JH, Rhee PL, et al. Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer. Endoscopy 2015;47(9):784-793. https://doi.org/10.1055/s-0034-1392249
  102. Chang JY, Shim KN, Tae CH, Lee KE, Lee J, Lee KH, et al. Comparison of clinical outcomes after endoscopic submucosal dissection and surgery in the treatment of early gastric cancer: A single-institute study. Medicine (Baltimore). 2017;96(30):e7210. https://doi.org/10.1097/MD.0000000000007210
  103. Chiu PW, Teoh AY, To KF, Wong SK, Liu SY, Lam CC, et al. Endoscopic submucosal dissection (ESD) compared with gastrectomy for treatment of early gastric neoplasia: a retrospective cohort study. Surg Endosc 2012;26(12):3584-3591. https://doi.org/10.1007/s00464-012-2371-8
  104. Cho JH, Cha SW, Kim HG, Lee TH, Cho JY, Ko WJ, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: A comparison study to surgery using propensity score-matched analysis. Surgical Endoscopy 2016;30(9):3762-3773. https://doi.org/10.1007/s00464-015-4672-1
  105. Feng F, Sun L, Xu G, Cai L, Hong L, Yang J, et al. Is it reasonable to treat early gastric cancer with mucosal infiltration and well differentiation by endoscopic submucosal resection. J Gastrointest Surg 2015;19(12):2111-2119. https://doi.org/10.1007/s11605-015-2932-y
  106. Fukunaga S, Nagami Y, Shiba M, Ominami M, Tanigawa T, Yamagami H, et al. Long-term prognosis of expanded-indication differentiated-type early gastric cancer treated with endoscopic submucosal dissection or surgery using propensity score analysis. Gastrointest Endosc 2017;85(1):143-152. https://doi.org/10.1016/j.gie.2016.06.049
  107. Gong EJ, Kim DH, Ahn JY, Jung KW, Lee JH, Choi KD, et al. Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma. Gastric Cancer 2017;20(Suppl 1):84-91. https://doi.org/10.1007/s10120-016-0679-0
  108. Kim YI, Kim YW, Choi IJ, Kim CG, Lee JY, Cho SJ, et al. Long-term survival after endoscopic resection versus surgery in early gastric cancers. Endoscopy 2015;45(4):293-301.
  109. Pyo JH, Lee H, Min BH, Lee JH, Choi MG, Lee JH, et al. Long-term outcome of endoscopic resection vs. surgery for early gastric cancer: A non-inferiority-matched cohort study. Am J Gastroenterol 2016;111(2):240-249. https://doi.org/10.1038/ajg.2015.427
  110. Fujiya K, Takizawa K, Tokunaga M, Kawata N, Hikage M, Makuuchi R, et al. The value of diagnostic endoscopic submucosal dissection for patients with clinical submucosal invasive early gastric cancer. Gastric Cancer 2018;21(1):124-132. https://doi.org/10.1007/s10120-017-0724-7
  111. Lee HD, Chung H, Kim SG, Kim J, Kim JL, Lee E, et al. Exploring the possibility of endoscopic submucosal dissection for clinical submucosal invasive early gastric cancers. Surgical Endoscopy. 2019.
  112. Kim DY, Joo JK, Ryu SY, Kim YJ, Kim SK. Factors related to lymph node metastasis and surgical strategy used to treat early gastric carcinoma. World J Gastroenterol 2004;10(5):737-740. https://doi.org/10.3748/wjg.v10.i5.737
  113. Kim JH, Lee YC, Kim H, Song KH, Lee SK, Cheon JH, et al. Endoscopic resection for undifferentiated early gastric cancer. Gastrointest Endosc 2009;69(4):e1-9. https://doi.org/10.1016/j.gie.2008.10.040
  114. Abe SO, I. Suzuki, H. Nonaka, S. Yoshinaga, S. Odagaki, T. Taniguchi, H. Kushima, R. Saito, Y. Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy 2013;45(9):703-707. https://doi.org/10.1055/s-0033-1344396
  115. Ahn JY, Park HJ, Park YS, Lee JH, Choi KS, Jeong KW, et al. Endoscopic resection for undifferentiated-type early gastric cancer: Immediate endoscopic outcomes and long-term survivals. Dig Dis Sci 2016;61(4):1158-1164. https://doi.org/10.1007/s10620-015-3988-y
  116. Kim JH, Kim YH, Jung DH, Jeon HH, Lee YC, Lee H, et al. Follow-up outcomes of endoscopic resection for early gastric cancer with undifferentiated histology. Surgical endoscopy 2014;28(9):2627-2633. https://doi.org/10.1007/s00464-014-3514-x
  117. Oda I, Oyama T, Abe S, Ohnita K, Kosaka T, Hirasawa K, et al. Preliminary results of multicenter questionnaire study on long-term outcomes of curative endoscopic submucosal dissection for early gastric cancer. Dig Endosc 2014;26(2):214-219. https://doi.org/10.1111/den.12141
  118. Park JC, Lee YK, Kim SY, Roh Y, Hahn KY, Shin SK, et al. Long-term outcomes of endoscopic submucosal dissection in comparison to surgery in undifferentiated-type intramucosal gastric cancer using propensity score analysis. Surgical Endoscopy 2018;32(4):2046-2057. https://doi.org/10.1007/s00464-017-5901-6
  119. Fujishiro M, Chiu PW, Wang HP. Role of antisecretory agents for gastric endoscopic submucosal dissection. Dig Endosc 2013;25 Suppl 1:86-93. https://doi.org/10.1111/j.1443-1661.2012.01370.x
  120. Ono H, Yao K, Fujishiro M, Oda I, Nimura S, Yahagi N, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc 2016;28(1):3-15. https://doi.org/10.1111/den.12518
  121. Park CH, Lee SK. Preventing and controlling bleeding in gastric endoscopic submucosal dissection. Clin Endosc 2013;46(5):456-462. https://doi.org/10.5946/ce.2013.46.5.456
  122. Takizawa K, Oda I, Gotoda T, Yokoi C, Matsuda T, Saito Y, et al. Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection--an analysis of risk factors. Endoscopy 2008;40(3):179-183. https://doi.org/10.1055/s-2007-995530
  123. Kang SH, Lee K, Lee HW, Park GE, Hong YS, Min BH. Delayed perforation occurring after endoscopic submucosal dissection for early gastric cancer. Clin Endosc 2015;48(3):251-255. https://doi.org/10.5946/ce.2015.48.3.251
  124. Lee H, Cheoi KS, Chung H, Park JC, Shin SK, Lee SK, et al. Clinical features and predictive factors of coagulation syndrome after endoscopic submucosal dissection for early gastric neoplasm. Gastric Cancer 2012;15(1):83-90. https://doi.org/10.1007/s10120-011-0073-x
  125. Uedo N, Takeuchi Y, Yamada T, Ishihara R, Ogiyama H, Yamamoto S, et al. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: A prospective randomized controlled trial. Am J Gastroenterol 2007;102(8):1610-1616. https://doi.org/10.1111/j.1572-0241.2007.01197.x
  126. Ye BD, Cheon JH, Choi KD, Kim SG, Kim JS, Jung HC, et al. Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial. Aliment Pharmacol Ther 2006;24(5):837-843. https://doi.org/10.1111/j.1365-2036.2006.03050.x
  127. Imaeda H, Hosoe N, Suzuki H, Saito Y, Ida Y, Nakamura R, et al. Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia. J Gastroenterol 2011;46(11):1267-1272. https://doi.org/10.1007/s00535-011-0447-1
  128. Tomita T, Kim Y, Yamasaki T, Okugawa T, Kondo T, Toyoshima F, et al. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection. J Gastroenterol Hepatol 2012;27(9):1441-2446. https://doi.org/10.1111/j.1440-1746.2012.07144.x
  129. Yang Z, Wu Q, Liu Z, Wu K, Fan D. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: A meta-analysis of randomized trials. Digestion 2011;84(4):315-320. https://doi.org/10.1159/000331138
  130. Arai M, Matsumura T, Okimoto K, Oyamada A, Saito K, Minemura S, et al. Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers. World J Gastroenterol 2014;20(43):16318-16322. https://doi.org/10.3748/wjg.v20.i43.16318
  131. Niimi K, Fujishiro M, Goto O, Kodashima S, Minatsuki C, Hirayama I, et al. Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection. Dig Endosc 2012;24(2):110-116. https://doi.org/10.1111/j.1443-1661.2011.01178.x
  132. Lee SH, Lee CK, Chung IK, Shim YS, Lee TH, Lee SH, et al. Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: A retrospective analysis and prospective validation study. Dig Dis Sci 2012;57(2):429-434. https://doi.org/10.1007/s10620-011-1941-2
  133. Shin WG, Kim SJ, Choi MH, Kim KO, Jang HJ, Park CH, et al. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers- A randomized, prospective, multicenter study. Gastrointest Endosc 2012;75(4):739-747. https://doi.org/10.1016/j.gie.2011.11.004
  134. Higuchi K, Takeuchi T, Uedo N, Takeuchi Y, Naito Y, Yagi N, et al. Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study. Gastric Cancer 2015;18(3):612-617. https://doi.org/10.1007/s10120-014-0404-9
  135. Fujiwara S, Morita Y, Toyonaga T, Kawakami F, Itoh T, Yoshida M, et al. A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection. J Gastroenterol 2011;46(5):595-602. https://doi.org/10.1007/s00535-011-0372-3
  136. Jung SW, Kim SY, Choe JW, Hyun JJ, Jung YK, Koo JS, et al. Standard and double-dose intravenous proton pump inhibitor injections for prevention of bleeding after endoscopic resection. J Gastroenterol Hepatol 2017;32(4):778-781. https://doi.org/10.1111/jgh.13597
  137. Park JH, Baek EK, Choi CH, Lee KH, Kim BJ, Kim JW, et al. Comparison of the efficacy of 4- and 8-week lansoprazole treatment for ESD-induced gastric ulcers: A randomized, prospective, controlled study. Surgical Endoscopy 2014;28(1):235-241. https://doi.org/10.1007/s00464-013-3177-z
  138. Nakamura K, Ihara E, Akiho H, Akahoshi K, Harada N, Ochiai T, et al. Limited effect of rebamipide in addition to proton pump inhibitor (PPI) in the treatment of post-endoscopic submucosal dissection gastric ulcers: A randomi zed controlled trial comparing PPI plus rebamipide combination therapy with PPI monotherapy. Gut Liver 2016;10(6):917-924. https://doi.org/10.5009/gnl15486
  139. Kawano S, Okada H, Kawahara Y, Hori K, Tanioka D, Tsuzuki T, et al. Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial. Digestion 2011;84(1):46-53. https://doi.org/10.1159/000321660
  140. Kim EH, Park SW, Nam E, Lee JG, Park CH. Comparative efficacy of various anti-ulcer medications after gastric endoscopic submucosal dissection: A systematic review and network meta-analysis. Surgical Endoscopy 2019;33(4):1271-1283. https://doi.org/10.1007/s00464-018-6409-4
  141. Oh TH, Jung HY, Choi KD, Lee GH, Song HJ, Choi KS, et al. Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks. Dig Dis Sci 2009;54(7):1494-1499. https://doi.org/10.1007/s10620-008-0506-5
  142. Park HJ, Kim HS, Kim BR, Park SY, Hong JH, Jo KW, et al. Half-dose rabeprazole has an equal efficacy to standard-dose rabeprazole on endoscopic submucosal dissectioninduced ulcer. Dig Dis Sci 2013;58(4):1054-1061. https://doi.org/10.1007/s10620-012-2436-5
  143. Mochizuki S, Uedo N, Oda I, Kaneko K, Yamamoto Y, Yamashina T, et al. Scheduled second-look endoscopy is not recommended after endoscopic submucosal dissection for gastric neoplasms (the SAFE trial): a multicentre prospective randomised controlled non-inferiority trial. Gut 2015;64(3):397-405. https://doi.org/10.1136/gutjnl-2014-307552
  144. Ryu HY, Kim JW, Kim HS, Park HJ, Jeon HK, Park SY, et al. Second-look endoscopy is not associated with better clinical outcomes after gastric endoscopic submucosal dissection: a prospective, randomized, clinical trial analyzed on an as-treated basis. Gastrointest Endosc 2013;78(2):285-294. https://doi.org/10.1016/j.gie.2013.02.008
  145. Nishizawa T, Suzuki H, Akimoto T, Maehata T, Morizane T, Kanai T, et al. Effects of preoperative proton pump inhibitor administration on bleeding after gastric endoscopic submucosal dissection: A systematic review and meta-analysis. United European Gastroenterol J 2016;4(1):5-10. https://doi.org/10.1177/2050640615588023
  146. Oda I, Suzuki H, Nonaka S, Yoshinaga S. Complications of gastric endoscopic submucosal dissection. Dig Endosc 2013;25 Suppl 1:71-78.
  147. Jeon SW, Jung MK, Kim SK, Cho KB, Park KS, Park CK, et al. Clinical outcomes for perforations during endoscopic submucosal dissection in patients with gastric lesions. Surgical Endoscopy 2010;24(4):911-916. https://doi.org/10.1007/s00464-009-0693-y
  148. Jeong G, Lee JH, Yu MK, Moon W, Rhee PL, Paik SW, et al. Non-surgical management of microperforation induced by EMR of the stomach. Dig Liver Dis 2006;38(8):605-608. https://doi.org/10.1016/j.dld.2006.04.016
  149. Minami S, Gotoda T, Ono H, Oda I, Hamanaka H. Complete endoscopic closure of gastric perforation induced by endoscopic resection of early gastric cancer using endoclips can prevent surgery (with video). Gastrointest Endosc 2006;63(4):596-601. https://doi.org/10.1016/j.gie.2005.07.029
  150. Paspatis GA, Dumonceau JM, Barthet M, Meisner S, Repici A, Saunders BP, et al. Diagnosis and management of iatrogenic endoscopic perforations: European society of gastrointestinal endoscopy (ESGE) position statement. Endoscopy 2014;46(8):693-711. https://doi.org/10.1055/s-0034-1377531
  151. Fu K, Ishikawa T, Yamamoto T, Kaji Y. Paracentesis for successful treatment of tension pneumoperitoneum related to endoscopic submucosal dissection. Endoscopy. 2009;41Suppl 2:E245. https://doi.org/10.1055/s-2007-966489
  152. Committee AT, Lo SK, Fujii-Lau LL, Enestvedt BK, Hwang JH, Konda V, et al. The use of carbon dioxide in gastrointestinal endoscopy. Gastrointest Endosc 2016;83(5):857-865. https://doi.org/10.1016/j.gie.2016.01.046
  153. Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011;14(2):113-123. https://doi.org/10.1007/s10120-011-0042-4
  154. Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda T, Taniguchi H, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer 2009;12(3):148-152. https://doi.org/10.1007/s10120-009-0515-x
  155. Pyo JH, Shin CM, Lee H, Min BH, Lee JH, Kim SM, et al. A Risk-prediction model based on lymph-node metastasis for incorporation into a treatment algorithm for signet ring cell-type intramucosal gastric cancer. Annals of Surgery 2016;264(6):1038-43. https://doi.org/10.1097/SLA.0000000000001602
  156. Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, et al. A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer: "eCura system". Am J Gastroenterol 2017;112(6):874-881. https://doi.org/10.1038/ajg.2017.95
  157. Kawata N, Kakushima N, Takizawa K, Tanaka M, Makuuchi R, Tokunaga M, et al. Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection. Surgical Endoscopy 2017;31(4):1607-1616. https://doi.org/10.1007/s00464-016-5148-7
  158. Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, et al. Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer- A multi-center retrospective study in Japan. J Gastroenterol 2017;52(2):175-184. https://doi.org/10.1007/s00535-016-1210-4
  159. Suzuki H, Oda I, Abe S, Sekiguchi M, Nonaka S, Yoshinaga S, et al. Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series. Gastric Cancer 2017;20(4):679- 689. https://doi.org/10.1007/s10120-016-0651-z
  160. Pyo JH, Lee H, Min YW, Min BH, Lee JH, Kim KM, et al. Feasibility of endoscopic resection in early gastric cancer with lymphovascular invasion. Annals of Surgical Oncology 2019;26(2):449-455. https://doi.org/10.1245/s10434-018-07119-4
  161. Choi JY, Jeon SW, Cho KB, Park KS, Kim ES, Park CK, et al. Non-curative endoscopic resection does not always lead to grave outcomes in submucosal invasive early gastric cancer. Surgical Endoscopy 2015;29(7):1842-1849. https://doi.org/10.1007/s00464-014-3874-2
  162. Toyokawa T, Ohira M, Tanaka H, Minamino H, Sakurai K, Nagami Y, et al. Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer. Surgical Endoscopy 2016;30(6):2404-414. https://doi.org/10.1007/s00464-015-4491-4
  163. Toya Y, Endo M, Nakamura S, Akasaka R, Kosaka T, Yanai S, et al. Clinical outcomes of non-curative endoscopic submucosal dissection with negative resected margins for gastric cancer. Gastrointest Endosc 2017;85(6):1218-1224. https://doi.org/10.1016/j.gie.2016.11.018
  164. Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, et al. Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer- A comparative study. Gastric Cancer 2018;21(3):481-489. https://doi.org/10.1007/s10120-017-0769-7
  165. Eom BW, Kim YI, Kim KH, Yoon HM, Cho SJ, Lee JY, et al. Survival benefit of additional surgery after noncurative endoscopic resection in patients with early gastric cancer. Gastrointest Endosc 2017;85(1):155-163 e3. https://doi.org/10.1016/j.gie.2016.07.036
  166. Kim ER, Lee H, Min BH, Lee JH, Rhee PL, Kim JJ, et al. Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer. Br J Surg 2015;102(11):1394-1401. https://doi.org/10.1002/bjs.9873
  167. Suzuki S, Gotoda T, Hatta W, Oyama T, Kawata N, Takahashi A, et al. Survival Benefit of additional surgery after non-curative endoscopic submucosal dissection for early gastric cancer: A propensity score matching analysis. Annals of Surgical Oncology 2017;24(11):3353-3360. https://doi.org/10.1245/s10434-017-6039-4
  168. Jung DH, Lee YC, Kim JH, Lee SK, Shin SK, Park JC, et al. Additive treatment improves survival in elderly patients after non-curative endoscopic resection for early gastric cancer. Surgical Endoscopy 2017;31(3):1376-1382. https://doi.org/10.1007/s00464-016-5123-3
  169. Kusano C, Iwasaki M, Kaltenbach T, Conlin A, Oda I, Gotoda T. Should elderly patients undergo additional surgery after non-curative endoscopic resection for early gastric cancer- Long-term comparative outcomes. Am J Gastroenterol 2011;106(6):1064-1069. https://doi.org/10.1038/ajg.2011.49
  170. Pyo JH, Lee H, Min BH, Lee JH, Kim KM, Yoo H, et al. Comparison of long-term outcomes after non-curative endoscopic resection in older patients with early gastric cancer. Annals of Surgical Oncology 2017;24(9):2624-2631. https://doi.org/10.1245/s10434-017-5888-1
  171. Sekiguchi M, Suzuki H, Oda I, Abe S, Nonaka S, Yoshinaga S, et al. Risk of recurrent gastric cancer after endoscopic resection with a positive lateral margin. Endoscopy 2014;46(4):273-278. https://doi.org/10.1055/s-0034-1364938
  172. Han JP, Hong SJ, Kim HK, Lee YN, Lee TH, Ko BM, et al. Risk stratification and management of non-curative resection after endoscopic submucosal dissection for early gastric cancer. Surgical Endoscopy 2016;30(1):184-189. https://doi.org/10.1007/s00464-015-4180-3
  173. Jeon MY, Park JC, Hahn KY, Shin SK, Lee SK, Lee YC. Long-term outcomes after noncurative endoscopic resection of early gastric cancer: The optimal time for additional endoscopic treatment. Gastrointest Endosc 2018;87(4):1003-1013e2. https://doi.org/10.1016/j.gie.2017.10.004
  174. Oh S, Kim SG, Choi JM, Jin EH, Kim JH, Im JP, et al. Ablation of residual gastric tumor by argon plasma coagulation after endoscopic resection. Surgical Endoscopy 2017;31(3):1093-1100. https://doi.org/10.1007/s00464-016-5069-5
  175. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label, randomised controlled trial. Lancet (London, England). 2008;372 (9636):392-397. https://doi.org/10.1016/S0140-6736(08)61159-9
  176. Kim SG, Jung HK, Lee HL, Jang JY, Lee H, Kim CG, et al. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. J Gastroenterol Hepatol 2014;29(7):1371-1386. https://doi.org/10.1111/jgh.12607
  177. Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the maastricht V/Florence consensus report. Gut 2017;66(1):6-30. https://doi.org/10.1136/gutjnl-2016-312288
  178. Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori infection. Am J Gastroenterol 2017;112(2):212-239. https://doi.org/10.1038/ajg.2016.563
  179. Mahachai V, Vilaichone RK, Pittayanon R, Rojborwonwitaya J, Leelakusolvong S, Maneerattanaporn M, et al. Helicobacter pylori management in ASEAN: The bangkok consensus report. J Gastroenterol Hepatol 2018;33(1):37-56. https://doi.org/10.1111/jgh.13911
  180. Liu WZ, Xie Y, Lu H, Cheng H, Zeng ZR, Zhou LY, et al. Fifth chinese national consensus report on the management of Helicobacter pylori infection. Helicobacter 2018; 23(2):e12475. https://doi.org/10.1111/hel.12475
  181. Yoon SB, Park JM, Lim CH, Cho YK, Choi MG. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: A meta-analysis. Helicobacter 2014;19(4):243-8. https://doi.org/10.1111/hel.12146
  182. Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, et al. Helicobacter pylori eradication for prevention of metachronous recurrence after endoscopic resection of early gastric cancer. Journal of Korean Medical Science 2015;30(6): 749-756. https://doi.org/10.3346/jkms.2015.30.6.749
  183. Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: A systematic review and meta-analysis. Gastroenterology 2016;150(5):1113-1124 e5. https://doi.org/10.1053/j.gastro.2016.01.028
  184. Sugano K. Effect of Helicobacter pylori eradication on the incidence of gastric cancer: A systematic review and meta-analysis. Gastric Cancer 2019;22(3):435-445. https://doi.org/10.1007/s10120-018-0876-0
  185. Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. The New England Journal of Medicine 2018;378(12):1085-1095. https://doi.org/10.1056/nejmoa1708423
  186. Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, et al. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: A randomized controlled trial. Gastrointest Endosc 2018;88(3):475-485 e2. https://doi.org/10.1016/j.gie.2018.05.009
  187. Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ, et al. [Synopsis on clinical practice guideline of gastric cancer in Korea: An evidence-based approach]. The Korean Journal of Gastroenterology=Taehan Sohwagi Hakhoe Chi 2014; 63(2):66-81. https://doi.org/10.4166/kjg.2014.63.2.66
  188. Kim SG, Park CM, Lee NR, Kim J, Lyu DH, Park SH, et al. Long-term clinical outcomes of endoscopic submucosal dissection in patients with early gastric cancer: A prospective multicenter cohort study. Gut Liver 2018;12(4):402-410. https://doi.org/10.5009/gnl17414
  189. Kato M, Nishida T, Yamamoto K, Hayashi S, Kitamura S, Yabuta T, et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: A multicentre retrospective cohort study by Osaka University ESD study group. Gut 2013;62(10):1425-1432. https://doi.org/10.1136/gutjnl-2011-301647
  190. Nasu J, Doi T, Endo H, Nishina T, Hirasaki S, Hyodo I. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy 2005;37(10):990-3. https://doi.org/10.1055/s-2005-870198
  191. Abe S, Oda I, Suzuki H, Nonaka S, Yoshinaga S, Nakajima T, et al. Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection. Endoscopy 2015;47(12):1113-1118. https://doi.org/10.1055/s-0034-1392484
  192. Hahn KY, Park JC, Kim EH, Shin S, Park CH, Chung H, et al. Incidence and impact of scheduled endoscopic surveillance on recurrence after curative endoscopic resection for early gastric cancer. Gastrointest Endosc 2016;84(4):628-38 e1. https://doi.org/10.1016/j.gie.2016.03.1404
  193. Yang HJ, Kim SG, Lim JH, Choi JM, Oh S, Park JY, et al. Novel risk stratification for metachronous recurrence after curative endoscopic submucosal dissection for early gastric cancer. Gastrointest Endosc 2018;87(2):419-428 e3. https://doi.org/10.1016/j.gie.2017.07.005
  194. Lee S, Choi KD, Hong SM, Park SH, Gong EJ, Na HK, et al. Pattern of extragastric recurrence and the role of abdominal computed tomography in surveillance after endoscopic resection of early gastric cancer: Korean experiences. Gastric Cancer 2017;20(5):843-852. https://doi.org/10.1007/s10120-017-0691-z
  195. Choi KS, Kim SH, Kim SG, Han JK. Early Gastric Cancers: Is CT surveillance necessary after curative endoscopic submucosal resection for cancers that meet the expanded criteria. Radiology 2016;281(2):444-453. https://doi.org/10.1148/radiol.2016152866
  196. Park CH, Kim EH, Chung H, Park JC, Shin SK, Lee SK, et al. Role of computed tomography scan for the primary surveillance of mucosal gastric cancer after complete resection by endoscopic submucosal dissection. Surgical Endoscopy 2014;28(4):1307-1313. https://doi.org/10.1007/s00464-013-3327-3
  197. Jung SA, Yang SK, Kang GH, Myung SA, Yu HS, Won SY, et al. Risk factors of lymph node metastasis in submucosally invasive colorectal carcinoma: With special reference to the depth of invasion. Korean J Gastrointest Endosc 2001;22(6):411-418.
  198. Choi PW, Yu CS, Jang SJ, Jung SH, Kim HC, Kim JC. Risk factors for lymph node metastasis in submucosal invasive colorectal cancer. World J Surg 2008;32(9):2089-2094. https://doi.org/10.1007/s00268-008-9628-3
  199. Sung HY, Kang WK, Kim SW, Nam KW, Jung CK, Chang JH, et al. Risk factors for lymph node metastasis in patients with submucosal invasive colorectal carcinoma. J Korean Surg Soc 2010;78(4):207-212. https://doi.org/10.4174/jkss.2010.78.4.207
  200. Lee SH, Kang HJ, Ahn BK, Baek SU, Chang HK, Oh NG, et al. Clinicopathologic factors for prediction of lymph node metastasis in submucosally invasive colorectal carcinoma. J Korean Surg Soc 2011;80(2):111-118. https://doi.org/10.4174/jkss.2011.80.2.111
  201. Ueno H, Hase K, Hashiguchi Y, Shimazaki H, Yoshii S, Kudo SE, et al. Novel risk factors for lymph node metastasis in early invasive colorectal cancer: A multi-institution pathology review. J Gastroenterol 2014;49(9):1314-1323. https://doi.org/10.1007/s00535-013-0881-3
  202. Han J, Hur H, Min BS, Lee KY, Kim NK. Predictive factors for lymph node metastasis in submucosal invasive colorectal carcinoma: A new proposal of depth of invasion for radical surgery. World J Surg 2018;42(8):2635-2641. https://doi.org/10.1007/s00268-018-4482-4
  203. Kim B, Kim EH, Park SJ, Cheon JH, Kim TI, Kim WH, et al. The risk of lymph node metastasis makes it unsafe to expand the conventional indications for endoscopic treatment of T1 colorectal cancer: A retrospective study of 428 patients. Medicine (Baltimore) 2016;95(37):e4373. https://doi.org/10.1097/md.0000000000004373
  204. Al-Sukhni E, Attwood K, Gabriel EM, LeVea CM, Kanehira K, Nurkin SJ. Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: A retrospective cohort study. Int J Surg 2017;37:42-49.
  205. Ha RK, Han KS, Sohn DK, Kim BC, Hong CW, Chang HJ, et al. Histopathologic risk factors for lymph node metastasis in patients with T1 colorectal cancer. Ann Surg Treat Res 2017;93(5):266-271. https://doi.org/10.4174/astr.2017.93.5.266
  206. Beaton C, Twine CP, Williams GL, Radcliffe AG. Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer. Colorectal Dis 2013;15(7):788-797. https://doi.org/10.1111/codi.12129
  207. Mou S, Soetikno R, Shimoda T, Rouse R, Kaltenbach T. Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: A systematic review and meta-analysis. Surg Endosc 2013;27(8):2692-2703. https://doi.org/10.1007/s00464-013-2835-5
  208. Choi JY, Jung SA, Shim KN, Cho WY, Keum B, Byeon JS, et al. Meta-analysis of predictive clinicopathologic factors for lymph node metastasis in patients with early colorectal carcinoma. J Korean Med Sci 2015;30(4):398-406. https://doi.org/10.3346/jkms.2015.30.4.398
  209. Tanaka S, Haruma K, Teixeira CR, Tatsuta S, Ohtsu N, Hiraga Y, et al. Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis. J Gastroenterol 1995;30(6):710-717. https://doi.org/10.1007/BF02349636
  210. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995;38(12):1286-1295. https://doi.org/10.1007/BF02049154
  211. Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy 1993;25(7):455-461. https://doi.org/10.1055/s-2007-1010367
  212. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: Implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985;89(2):328-336. https://doi.org/10.1016/0016-5085(85)90333-6
  213. Park YJ, Kim WH, Paeng SS, Park JG. Histoclinical analysis of early colorectal cancer. World Journal of Surgery. 2000;24(9):1029-1035. https://doi.org/10.1007/s002680010143
  214. Choi DH, Sohn DK, Chang HJ, Lim SB, Choi HS, Jeong SY. Indications for subsequent surgery after endoscopic resection of submucosally invasive colorectal carcinomas: A prospective cohort study. Dis Colon Rectum 2009;52(3):438-445. https://doi.org/10.1007/DCR.0b013e318197e37f
  215. Lim KH, Jung SW, Jeong ID, Bang SJ, Shin JW, Park NH, et al. Risk factors for lymph node metastasis after endoscopic resection for early colorectal cancer. Intest Res 2008;6(2):103-109.
  216. Lee SH, Cho HD, Park DI, Heo WJ, Sohn JH, Kim SE, et al. Pathological predictors for defining a therapeutic strategy for early colon cancer after endoscopic resection: Multi-center retrospective analysis from surgically resected specimens. Hepatogastroenterology 2014;61(131):642-646.
  217. Nakadoi K, Oka S, Tanaka S, Hayashi N, Terasaki M, Arihiro K, et al. Condition of muscularis mucosae is a risk factor for lymph node metastasis in T1 colorectal carcinoma. Surgical Endoscopy 2014;28(4):1269-1276. https://doi.org/10.1007/s00464-013-3321-9
  218. Nishida T, Egashira Y, Akutagawa H, Fujii M, Uchiyama K, Shibayama Y, et al. Predictors of lymph node metastasis in T1 colorectal carcinoma: An immunophenotypic analysis of 265 patients. Dis Colon Rectum. 2014;57(8):905-915. https://doi.org/10.1097/dcr.0000000000000168
  219. Kawachi H, Eishi Y, Ueno H, Nemoto T, Fujimori T, Iwashita A, et al. A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: A retrospective multicenter study. Modern Pathology 2015;28(6):872-879. https://doi.org/10.1038/modpathol.2015.36
  220. Barresi V, Reggiani Bonetti L, Vitarelli E, Di Gregorio C, Ponz de Leon M, Barresi G. Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol 2012;36(1):66-72. https://doi.org/10.1097/PAS.0b013e31822d3008
  221. Wada H, Shiozawa M, Katayama K, Okamoto N, Miyagi Y, Rino Y, et al. Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer. J Gastroenterol 2015;50(7):727-734. https://doi.org/10.1007/s00535-015-1057-0
  222. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;40(2):127-132. https://doi.org/10.1046/j.1365-2559.2002.01324.x
  223. Cappellesso R, Luchini C, Veronese N, Lo Mete M, RosaRizzotto E, Guido E, et al. Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: A meta-analysis. Human Pathology 2017;65:62-70. https://doi.org/10.1016/j.humpath.2017.04.013
  224. Masaki T, Matsuoka H, Sugiyama M, Abe N, Sakamoto A, Atomi Y. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J Gastroenterol Hepatol 2006;21(7):1115-1121. https://doi.org/10.1111/j.1440-1746.2006.04073.x
  225. Yim K, Won DD, Lee IK, Oh ST, Jung ES, Lee SH. Novel predictors for lymph node metastasis in submucosal invasive colorectal carcinoma. World J Gastroenterol 2017;23(32):5936-5944. https://doi.org/10.3748/wjg.v23.i32.5936
  226. Gangireddy VGR, Coleman T, Kanneganti P, Talla S, Annapureddy AR, Amin R, et al. Polypectomy versus surgery in early colon cancer: Size and location of colon cancer affect long-term survival. International Journal of Colorectal disease. 2018;33(10):1349-1357. https://doi.org/10.1007/s00384-018-3101-z
  227. Mounzer R, Das A, Yen RD, Rastogi A, Bansal A, Hosford L, et al. Endoscopic and surgical treatment of malignant colorectal polyps: A population-based comparative study. Gastrointest Endosc 2015;81(3):733-740 e2. https://doi.org/10.1016/j.gie.2014.11.049
  228. Kogler P, Kafka-Ritsch R, Ofner D, Sieb M, Augustin F, Pratschke J, et al. Is limited surgery justified in the treatment of T1 colorectal cancer. Surg Endosc 2013;27(3):817-825. https://doi.org/10.1007/s00464-012-2518-7
  229. Belderbos TD, van Erning FN, de Hingh IH, van Oijen MG, Lemmens VE, Siersema PD. Long-term recurrence-free survival after standard endoscopic resection versus surgical resection of submucosal invasive colorectal cancer: A popula tion-based study. Clin Gastroenterol Hepatol 2017;15(3):403-411 e1. https://doi.org/10.1016/j.cgh.2016.08.041
  230. Kim JB, Lee HS, Lee HJ, Kim J, Yang DH, Yu CS, et al. Long-term outcomes of endoscopic versus surgical resection of superficial submucosal colorectal cancer. Dig Dis Sci 2015;60(9):2785-2792. https://doi.org/10.1007/s10620-015-3530-2
  231. Heo J, Jeon SW, Jung MK, Kim SK, Kim J, Kim S. Endoscopic resection as the first-line treatment for early colorectal cancer: Comparison with surgery. Surgical Endoscopy 2014;28(12):3435-3442. https://doi.org/10.1007/s00464-014-3618-3
  232. Yoda Y, Ikematsu H, Matsuda T, Yamaguchi Y, Hotta K, Kobayashi N, et al. A large-scale multicenter study of long-term outcomes after endoscopic resection for submucosal invasive colorectal cancer. Endoscopy 2013;45(9):718-724. https://doi.org/10.1055/s-0033-1344234
  233. Yoshii S, Nojima M, Nosho K, Omori S, Kusumi T, Okuda H, et al. Factors associated with risk for colorectal cancer recurrence after endoscopic resection of T1 tumors. Clin Gastroenterol Hepatol 2014;12(2):292-302 e3. https://doi.org/10.1016/j.cgh.2013.08.008
  234. Asayama N, Oka S, Tanaka S, Ninomiya Y, Tamaru Y, Shigita K, et al. Long-term outcomes after treatment for T1 colorectal carcinoma. International Journal of Colorectal Disease 2016;31(3):571-578. https://doi.org/10.1007/s00384-015-2473-6
  235. Tamaru Y, Oka S, Tanaka S, Nagata S, Hiraga Y, Kuwai T, et al. Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group. J Gastroenterol 2017;52(11):1169-1179. https://doi.org/10.1007/s00535-017-1318-1
  236. Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Watanabe H. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 1996;44(1):8-14. https://doi.org/10.1016/S0016-5107(96)70222-5
  237. Hurlstone DP, Cross SS, Adam I, Shorthouse AJ, Brown S, Sanders DS, et al. Endoscopic morphological anticipation of submucosal invasion in flat and depressed colorectal lesions: Clinical implications and subtype analysis of the kudo type V pit pattern using high-magnification-chromoscopic colonoscopy. Colorectal Dis 2004;6(5):369-375. https://doi.org/10.1111/j.1463-1318.2004.00667.x
  238. Ohta T, Tomigana K, Sakai Y. Efficacy of magnifying colonoscopy for the diagnosis of colorectal neoplasia: Comparison with histopathological findings. Dig Endosc 2004;16:308-314. https://doi.org/10.1111/j.1443-1661.2004.00407.x
  239. Tanaka S, Haruma K, Nagata S, Oka S, Chayama K. Diagnosis of invasion depth in early colorectal carcinoma by pit pattern analysis with magnifying endoscopy. Dig Endosc 2001;13:S2-S5. https://doi.org/10.1111/j.1443-1661.2001.00107.x
  240. Matsuda T, Fujii T, Saito Y, Nakajima T, Uraoka T, Kobayashi N, et al. Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol 2008;103(11):2700-2706. https://doi.org/10.1111/j.1572-0241.2008.02190.x
  241. Zhang QW, Teng LM, Zhang XT, Zhang JJ, Zhou Y, Zhou ZR, et al. Narrow-band imaging in the diagnosis of deep submucosal colorectal cancers: A systematic review and meta-analysis. Endoscopy 2017;49(6):564-580. https://doi.org/10.1055/s-0043-103014
  242. Hirata M, Tanaka S, Oka S, Kaneko I, Yoshida S, Yoshihara M, et al. Evaluation of microvessels in colorectal tumors by narrow band imaging magnification. Gastrointest Endosc 2007;66(5):945-952. https://doi.org/10.1016/j.gie.2007.05.053
  243. Wada Y, Kudo SE, Kashida H, Ikehara N, Inoue H, Yamamura F, et al. Diagnosis of colorectal lesions with the magnifying narrow-band imaging system. Gastrointest Endosc 2009;70(3):522-531. https://doi.org/10.1016/j.gie.2009.01.040
  244. Yoo HY, Lee MS, Ko BM, Kim HK, Ahn HS, Han SH, et al. Correlation of narrow band imaging with magnifying colonoscopy and histology in colorectal tumors. Clin Endosc 2011;44(1):44-50. https://doi.org/10.5946/ce.2011.44.1.44
  245. Ikematsu H, Matsuda T, Emura F, Saito Y, Uraoka T, Fu KI, et al. Efficacy of capillary pattern type IIIA/IIIB by magnifying narrow band imaging for estimating depth of invasion of early colorectal neoplasms. BMC Gastroenterol 2010;10:33. https://doi.org/10.1186/1471-230X-10-33
  246. Oba S, Tanaka S, Oka S, Kanao H, Yoshida S, Shimamoto F, et al. Characterization of colorectal tumors using narrow-band imaging magnification: Combined diagnosis with both pit pattern and microvessel features. Scandinavian Journal of Gastroenterology 2010;45(9):1084-1092. https://doi.org/10.3109/00365521003734166
  247. Sumimoto K, Tanaka S, Shigita K, Hirano D, Tamaru Y, Ninomiya Y, et al. Clinical impact and characteristics of the narrow-band imaging magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Gastrointest Endosc 2017;85(4):816-821. https://doi.org/10.1016/j.gie.2016.07.035
  248. Iwatate M, Sano Y, Tanaka S, Kudo SE, Saito S, Matsuda T, et al. Validation study for development of the Japan NBI Expert Team classification of colorectal lesions. Dig Endosc 2018;30(5):642-651. https://doi.org/10.1111/den.13065
  249. Li X, Chen H, Gao Y, Chen X, Ge Z. Prediction of histology and invasive depth of colorectal neoplasia based on morphology of surface depression using magnifying chromocolonoscopy. International Journal of Colorectal Disease 2010;25(1):79-85. https://doi.org/10.1007/s00384-009-0821-0
  250. Hisabe T, Tsuda S, Hoashi T, Ishihara H, Yamasaki K, Yasaka T, et al. Validity of conventional endoscopy using "non-extension sign" for optical diagnosis of colorectal deep submucosal invasive cancer. Endosc Int Open 2018;6(2):E156-E164. https://doi.org/10.1055/s-0043-121881
  251. Uno Y, Munakata A. The non-lifting sign of invasive colon cancer. Gastrointest Endosc 1994;40(4):485-489. https://doi.org/10.1016/S0016-5107(94)70216-0
  252. Kobayashi N, Saito Y, Sano Y, Uragami N, Michita T, Nasu J, et al. Determining the treatment strategy for colorectal neoplastic lesions: Endoscopic assessment or the non-lifting sign for diagnosing invasion depth. Endoscopy 2007;39(8):701-705. https://doi.org/10.1055/s-2007-966587
  253. Sakamoto T, Nakajima T, Matsuda T, Murakami Y, Ishikawa H, Yao K, et al. Comparison of the diagnostic performance between magnifying chromoendoscopy and magnifying narrow-band imaging for superficial colorectal neoplasms: An online survey. Gastrointest Endosc 2018;87(5):1318-1323. https://doi.org/10.1016/j.gie.2017.12.021
  254. De Ceglie A, Hassan C, Mangiavillano B, Matsuda T, Saito Y, Ridola L, et al. Endoscopic mucosal resection and endoscopic submucosal dissection for colorectal lesions: A systematic review. Crit Rev Oncol Hematol 2016;104:138-155. https://doi.org/10.1016/j.critrevonc.2016.06.008
  255. Belderbos TD, Leenders M, Moons LM, Siersema PD. Local recurrence after endoscopic mucosal resection of nonpedunculated colorectal lesions: Systematic review and meta-analysis. Endoscopy 2014;46(5):388-402. https://doi.org/10.1055/s-0034-1364970
  256. Fuccio L, Repici A, Hassan C, Ponchon T, Bhandari P, Jover R, et al. Why attempt en bloc resection of non-pedunculated colorectal adenomas. A systematic review of the prevalence of superficial submucosal invasive cancer after endoscopic submucosal dissection. Gut 2018;67(8):1464-1474. https://doi.org/10.1136/gutjnl-2017-315103
  257. Fujiya M, Tanaka K, Dokoshi T, Tominaga M, Ueno N, Inaba Y, et al. Efficacy and adverse events of EMR and endoscopic submucosal dissection for the treatment of colon neoplasms: A meta-analysis of studies comparing EMR and endoscopic submucosal dissection. Gastrointest Endosc 2015;81(3):583-595. https://doi.org/10.1016/j.gie.2014.07.034
  258. Arezzo A, Passera R, Marchese N, Galloro G, Manta R, Cirocchi R. Systematic review and meta-analysis of endoscopic submucosal dissection vs. Endoscopic mucosal resection for colorectal lesions. United European Gastroenterol J 2016;4(1):18-29. https://doi.org/10.1177/2050640615585470
  259. Liggi M. Endoscopic submucosal dissection, endoscopic mucosal resection and hybrid techniques for large nonpedunculated colorectal tumors: A meta analysis and systematic review. J Interv Gastroenterol 2014;4(4):117-125. https://doi.org/10.7178/jig.173
  260. Sato T, Fukuzawa M, Gotoda T, Moriyasu F. Comparison of clinical outcomes between colorectal EMR and ESD. J Tokyo Med Univ 2016;74(2):154-162.
  261. Repici A, Hassan C, De Paula Pessoa D, Pagano N, Arezzo A, Zullo A, et al. Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: A systematic review. Endoscopy 2012;44(2):137-150. https://doi.org/10.1055/s-0031-1291448
  262. Shiga H, Endo K, Kuroha M, Kakuta Y, Takahashi S, Kinouchi Y, et al. Endoscopic submucosal dissection for colorectal neoplasia during the clinical learning curve. Surg Endosc 2014;28(7):2120-2128. https://doi.org/10.1007/s00464-014-3443-8
  263. Sakamoto T, Saito Y, Fukunaga S, Nakajima T, Matsuda T. Learning curve associated with colorectal endoscopic submucosal dissection for endoscopists experienced in gastric endoscopic submucosal dissection. Dis Colon Rectum 2011;54(10):1307-1312. https://doi.org/10.1097/DCR.0b013e3182282ab0
  264. Bhurwal A, Bartel MJ, Heckman MG, Diehl NN, Raimondo M, Wallace MB, et al. Endoscopic mucosal resection: Learning curve for large nonpolypoid colorectal neoplasia. Gastroin-test Endosc 2016;84(6):959-968 e7. https://doi.org/10.1016/j.gie.2016.04.020
  265. Probst A, Golger D, Anthuber M, Markl B, Messmann H. Endoscopic submucosal dissection in large sessile lesions of the rectosigmoid: Learning curve in a European center. Endoscopy 2012;44(7):660-667. https://doi.org/10.1055/s-0032-1309403
  266. Jeon HH, Lee HS, Youn YH, Park JJ, Park H. Learning curve analysis of colorectal endoscopic submucosal dissection (ESD) for laterally spreading tumors by endoscopists experienced in gastric ESD. Surgical Endoscopy 2016;30(6):2422-2430. https://doi.org/10.1007/s00464-015-4493-2